DE60330914D1 - Arzneimittel mit shikonin als wirkstoff - Google Patents

Arzneimittel mit shikonin als wirkstoff

Info

Publication number
DE60330914D1
DE60330914D1 DE60330914T DE60330914T DE60330914D1 DE 60330914 D1 DE60330914 D1 DE 60330914D1 DE 60330914 T DE60330914 T DE 60330914T DE 60330914 T DE60330914 T DE 60330914T DE 60330914 D1 DE60330914 D1 DE 60330914D1
Authority
DE
Germany
Prior art keywords
shikonin
drugs
active substance
alkannin
hematopathy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60330914T
Other languages
English (en)
Inventor
Feixin Wang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beijing JBC Chinese Traditional Medicine Science and Tech Develop Co Ltd
Original Assignee
Beijing JBC Chinese Traditional Medicine Science and Tech Develop Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beijing JBC Chinese Traditional Medicine Science and Tech Develop Co Ltd filed Critical Beijing JBC Chinese Traditional Medicine Science and Tech Develop Co Ltd
Application granted granted Critical
Publication of DE60330914D1 publication Critical patent/DE60330914D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C50/00—Quinones
    • C07C50/26—Quinones containing groups having oxygen atoms singly bound to carbon atoms
    • C07C50/32—Quinones containing groups having oxygen atoms singly bound to carbon atoms the quinoid structure being part of a condensed ring system having two rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
DE60330914T 2003-02-21 2003-02-21 Arzneimittel mit shikonin als wirkstoff Expired - Lifetime DE60330914D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2003/000138 WO2004073699A1 (en) 2003-02-21 2003-02-21 Pharmaceuticals comprising shikonins as active constituent

Publications (1)

Publication Number Publication Date
DE60330914D1 true DE60330914D1 (de) 2010-02-25

Family

ID=32873525

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60330914T Expired - Lifetime DE60330914D1 (de) 2003-02-21 2003-02-21 Arzneimittel mit shikonin als wirkstoff

Country Status (8)

Country Link
EP (1) EP1595536B1 (de)
JP (1) JP4372017B2 (de)
CN (1) CN100370976C (de)
AT (1) ATE454139T1 (de)
AU (1) AU2003220773A1 (de)
DE (1) DE60330914D1 (de)
HK (1) HK1085386A1 (de)
WO (1) WO2004073699A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1307987C (zh) * 2005-07-25 2007-04-04 北京羚锐伟业科技有限公司 紫草素的新用途
MX2008012905A (es) * 2006-04-07 2009-02-20 Sunten Phytotech Co Ltd Compuestos de naftalendiona.
CN101863766B (zh) * 2010-06-26 2013-06-12 上海交通大学 β-羟基异戊酰紫草素衍生物及其制备方法
ES2596169T3 (es) * 2010-10-21 2017-01-05 Ambros HÜGIN Métodos y composiciones para tratar infecciones por poxvirus con una 1,4-naftoquinona como principio activo
CN102048716A (zh) * 2010-12-20 2011-05-11 昆明理工大学 对苯二酚化合物的新用途
CN103130680B (zh) * 2013-02-04 2014-12-10 上海交通大学 高光学纯度紫草素和阿卡宁萘茜母核羟基甲基化羰基肟衍生物及其制备和用途
CN104130164B (zh) * 2014-07-09 2016-05-04 上海交通大学 外消旋体紫草素萘茜母核羟基甲基化磺酸钠衍生物
AU2018218164B2 (en) 2017-02-10 2023-12-21 Menicon Co., Ltd. Agent for inducing stress tolerance in plants
CN110448546A (zh) * 2019-05-13 2019-11-15 安徽医科大学 紫草素在制备治疗乙型肝炎病毒感染药物中的应用
CN114933522B (zh) * 2022-06-17 2023-10-17 石河子大学 一种紫草素类化合物的制备方法及其应用
CN115998719A (zh) * 2022-12-21 2023-04-25 右江民族医学院 去氧紫草素在制备抗幽门螺杆菌药物中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1046631C (zh) * 1995-03-18 1999-11-24 新疆维吾尔自治区林业科学研究院 紫草色素抑菌唇膏
CN1058290C (zh) * 1995-06-13 2000-11-08 中国科学院植物研究所 新疆紫草细胞固体两步培养生产工艺
CN1085708C (zh) * 1999-11-29 2002-05-29 徐淑梅 紫草红色素的提取方法
CN1178678C (zh) * 2001-02-22 2004-12-08 宋安麟 医疗功效广谱的紫草剂制备方法

Also Published As

Publication number Publication date
EP1595536A4 (de) 2007-07-18
AU2003220773A1 (en) 2004-09-09
JP4372017B2 (ja) 2009-11-25
CN100370976C (zh) 2008-02-27
EP1595536B1 (de) 2010-01-06
WO2004073699A1 (en) 2004-09-02
WO2004073699A8 (fr) 2004-11-11
ATE454139T1 (de) 2010-01-15
EP1595536A1 (de) 2005-11-16
CN1744888A (zh) 2006-03-08
HK1085386A1 (en) 2006-08-25
JP2006514663A (ja) 2006-05-11

Similar Documents

Publication Publication Date Title
HK1085386A1 (en) Pharmaceuticals comprising shikonins active constituent
ATE496643T1 (de) Verwendung von antioxidantien zur verhinderung von oxidation und zur reduzierung von wirkstoffzersetzung in wirkstoffhaltigen medizinischen artikeln
BRPI0415525A (pt) derivados de imidazola e seu uso como agentes farmacêuticos
ATE314063T1 (de) Valproinsäure zur behandlung von brustkrebs, dickdarmkrebs, kopf-hals-krebs, kleinzelligem lungenkarzinom und blutzellenkrebs in kombination mit bestrahlung
WO2003096990A3 (en) Protein cages for the delivery of medical imaging and therapy
MX2009003504A (es) Dispositivo para suministro local y/o regional que utiliza formulaciones liquidas de agentes terapeuticos.
NZ544472A (en) Compounds and therapeutical use thereof
BRPI0407897A (pt) derivados de cianopiridina úteis no tratamento de cáncer e outros distúrbios
CY1105849T1 (el) Χρηση αντισηπτικων στην εμπορικη κατασκευη φαρμακευτικου παρασκευασματος προς αποτροπη ή θepαπεια εναντι φλεγμονων εντος του ανθρωπινου σωματος
CY1110078T1 (el) Παρασκευασματα με ιωδιουχο ποβιδονη για την αγωγη τραυματων
TW200510392A (en) Chemical compounds
TR200103819T2 (tr) kanser tedavisinde ET743 terkipleri ve kullanımları
TR200101633T2 (tr) Farmasötik bileşim
LT2006024A (en) Tetrapeptide regulating blood glucose level in diabetes mellitus
NO995838L (no) Nye heteroetynylenforbindelser og farmasoeytiske og kosmetiske preparater inneholdende de samme
ATE409039T1 (de) Kombinationstherapie gegen krebserkrankungen mit azd2171 und zd1839
ATE385798T1 (de) Pharmazeutische zubereitungen enthaltend azd 2171 und zd 6126 und verwendungen
ITBO20030261A1 (it) Unita'di irraggiamento luminoso per diagnosi e cura di problemi cutanei.
NZ538926A (en) Medicament containing disorazoles and derivatives thereof for the treatment of benign and malignant tumoral diseases
ATE245421T1 (de) Pharmazeutische zusammensetzung welche riluzol und gabapentin enthält zur behandung von motoneuronalen krankheiten
DK1196439T3 (da) Forbindelser udvisende en antibiotikaaktivitet
ATE405249T1 (de) Körpergeruch verändernde biologisch aktive substanzen
MXPA02007641A (es) Uso de farmaceutico de la combinacion de fluconazol-tinidazol y su composicion para la administracion oral.
ATE339209T1 (de) Kombinationstherapie mit gemzitabin und zd6126
DE60308127D1 (de) Pharmazeutische Zusammentsetzung zur medizinischen Behandlung von gutartiger prostathyperplasie, dessen Vorbereitungsmethode und dessen therapeutische Verwendung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition